MyFinsight
Home
Blog
About
Contact
Back
Income Statement
enGene Therapeutics Inc. (ENGN)
enGene Therapeutics Inc. (ENGN)
source: myfinsight.com
Total comprehensive
loss
-$30,526K
Net loss
-$30,227K
Unrealized loss (gain) on
available-for-sale investments
-$299K
Interest income
$2,663K
Net loss before
income taxes
-$30,227K
Total other income,
net
$1,741K
Interest expense
$745K
Other expenses, net
-$177K
Loss from operations
-$31,968K
Total operating
expenses
$31,968K
Research and development
$22,195K
General and
administrative
$9,773K
Back